Grants and Contributions:
Title:
Clinical-Ready Portable EVOSS Lung Device Development
Agreement Number:
932836
Agreement Value:
$440,000.00
Agreement Date:
Aug 1, 2019 - Jun 30, 2021
Description:
This project will advance the engineering and design of EVOSS Lung to the point of total readiness for pivotal clinical trials and pilot production and field testing of a remarkably portable, usable, beautiful machine.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Edmonton, Alberta, CA T5J 4P6
Reference Number:
172-2019-2020-Q2-932836
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
821124799
Recipient Type:
For-profit organization
Recipient's Legal Name:
Tevosol Inc.
Federal Riding Name:
Edmonton Centre
Federal Riding Number:
48014
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
33451